Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
30 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
LYS MEDICAL from Charleroi, company number BE0688626061, closed financial year 2025 with a result of € -1.1 million after tax. For that financial year LYS MEDICAL recorded a gross margin of € -309,203 and equity of € 115,977. Compared with financial year 2024, the result moved from € -989,987 to € -1.1 million. The company made a loss. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.
€ 115,977
▲ € 489,475 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1.1 million
▼ 16 % more loss than in 2024
Profit after tax over the fiscal year.
€ 323,417
▲ 110% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.6 million.
People and assets in 2025
€ 501,375
▲ 17% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 9,975
▲ 1% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 186,047
▼ 77% vs 2024
€ 66,551 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 173,246
▲ € 144,913 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 66,107
▼ 11% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -232,902 | € -302,677 | € -93,354 | € -309,203 | ▼ € 215,848 |
| Profit after taxes | € -1,142,936 | € -1,253,244 | € -989,987 | € -1,147,806 | ▼ € 157,819 |
| Equity | € 1,417,127 | € 940,853 | € -373,497 | € 115,977 | ▲ € 489,475 |
| Total debts | € 1,039,124 | € 1,219,486 | € 1,860,907 | € 1,138,172 | ▼ 39% |
| Cash | € 842,071 | € 473,560 | € 154,373 | € 323,417 | ▲ 110% |
| Retained profit | € -2,344,375 | € -753,244 | € -1,743,231 | € -1,641,037 | ▲ € 102,194 |
| Bank debt | € 582,857 | € 295,143 | € 824,613 | € 186,047 | ▼ 77% |
| Balance sheet total | € 2,456,251 | € 2,160,339 | € 1,487,409 | € 1,254,149 | ▼ 16% |
Key figures of LYS MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to LYS MEDICAL?
What happened at LYS MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Olivier Fructus stepped down as director. NBB
- Devière Jacques stepped down as director. NBB
- CANA SS SS stepped down as director. NBB
- Mertens Benjamin stepped down as director. NBB
- Sylvain Landau stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 1.1 million. Source: NBB ↗
- Olivier Fructus became a director. NBB
- Devière Jacques became a director. NBB
In short
From € 1.1 million loss in 2022 to € 1.1 million loss in 2025.
Paid € 2,597 in corporate taxes since 2022.
A new publication or filing at LYS MEDICAL? We notify you, reason included.
Follow LYS MEDICALDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of FONDS DE CAPITAL A RISQUE 2020, GIPHIC comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
LYS MEDICALThe shares are held by FONDS DE CAPITAL A RISQUE 2020 (18.3%) and GIPHIC (0.1%).
Directors
According to the 2025 annual accounts
Devière Jacques
Director
since 2023 · until 2027
Director · represented by Prignon Anne
since 2023 · until 2027
Mertens Benjamin
Managing director
since 2023 · until 2027
Olivier Fructus
Director
since 2024 · until 2030
Sylvain Landau
Director
since 2023 · until 2027
Shareholders
0.1%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue Clément Ader 10
6041 Charleroi
Rue Bruyère-Saint-Jean 7A
1410 Waterloo
Active since 1 November 2019
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 30 companies are registered at this address.
All companies at this address →Brussels South Charleroi BioPark Dev
€ 80,186 gross margin · 2025
ImmunXperts
€ 393,338 gross margin · 2024
SPECTRALYS BIOTECH
€ 143,689 gross margin · 2025
ProtonW.be
€ -7,643 gross margin · 2025
QbD Wallonia
€ 1.5 million gross margin · 2025
+25 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
OVH, FR
Domain
Domain
lysmedical.com
Registered
2017-08-16
Registrar
OVH sas
Expires
2030-08-16
Website info
Features
Security
Network
Details
- Company number
- 0688.626.061
- VAT number
- BE 0688.626.061
- Registered office
- Rue Clément Ader 10, 6041 Charleroi
- Names & denominations
- LYS MEDICAL
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 18 January 2018
- Peppol
- Active · Active since 17 Mar 2025
- Contact
- lysmedical.com [email protected]
- Activities · NACE
Ontwerpen van computerprogramma’s
Speur- en ontwikkelingswerk op biotechnologisch gebied
Ontwerpen en programmeren van computerprogramma's